Dynavax Technologies Corp

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.50

+0.00 (+0.00%)

As of Mar 22, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target -10.3% upside

Low Target $9.87

Average Target $13.91

High Target $23.13

Current Price $15.50

Current
$15.50

Target
$13.91

$9.87 $13.91 avg $23.13

Scenario Analysis

Bear Case

$9.87

-36.3%

Low target

Base Case

$13.91

-10.3%

Avg target

Bull Case

$23.13

+49.2%

High target

Risk/Reward

1.4x

Balanced

Price in Context

52-Week High

$15.73

-1.5% from high

52-Week Low

$9.20

+68.5% from low

Target vs 52W High

$13.91

-11.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%